4503.T · Japan · Healthcare
As of July 13, 2026 at 08:56 PM KST, ASTELLAS PHARMA (4503.T) has a market cap of $23B (≈ ¥3.8T) — #192 worldwide on this unified board of 300 major Korean, US, and Japanese stocks, and #72 among Japan names. Down 4 spots from yesterday's baseline.
Compared with global #1 NVIDIA Corporation ($5.11T), that is 0.5% — it would take 218.5× ASTELLAS PHARMA to match one NVIDIA Corporation. The gap to #191 Samsung SDI ($24B) right above is $368M. Right below at #193 is CANON INC ($23B).
Within the Healthcare sector it ranks #22 of 26; the sector leader is Eli Lilly and Company (global #13). The stock trades at $13.05, with roughly 1.79B shares outstanding (estimated).